WooGene B&G Co. Ltd (KQ:018620) — Market Cap & Net Worth
Market Cap & Net Worth: WooGene B&G Co. Ltd (018620)
WooGene B&G Co. Ltd (KQ:018620) has a market capitalization of $47.07 Million (₩69.46 Billion) as of September 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #22205 globally and #1393 in its home market, demonstrating a -1.47% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying WooGene B&G Co. Ltd's stock price ₩2675.00 by its total outstanding shares 25965800 (25.97 Million). Also see WooGene B&G Co. Ltd balance sheet assets for a full breakdown of the balance sheet.
WooGene B&G Co. Ltd Market Cap History: 2015 to 2026
WooGene B&G Co. Ltd's market capitalization history from 2015 to 2026. Data shows change from $62.83 Million to $47.07 Million (-1.92% CAGR). Also see WooGene B&G Co. Ltd (018620) cash conversion ratio for how efficiently the company converts equity into cash flow.
Index Memberships
WooGene B&G Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$234.31 Billion | 0.02% | #667 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$234.31 Billion | 0.02% | #667 of 1384 |
Weight: WooGene B&G Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
WooGene B&G Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how WooGene B&G Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest WooGene B&G Co. Ltd stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.00x
WooGene B&G Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $62.83 Million | $23.51 Billion | $352.76 Million | 0.00x | 0.18x |
| 2016 | $95.40 Million | $27.82 Billion | $175.43 Million | 0.00x | 0.54x |
| 2017 | $68.97 Million | $26.43 Billion | -$4.19 Billion | 0.00x | N/A |
| 2018 | $32.72 Million | $30.62 Billion | -$6.63 Billion | 0.00x | N/A |
| 2019 | $43.11 Million | $33.62 Billion | -$12.79 Billion | 0.00x | N/A |
| 2020 | $50.59 Million | $39.52 Billion | -$2.06 Billion | 0.00x | N/A |
| 2021 | $36.95 Million | $39.35 Billion | -$2.26 Billion | 0.00x | N/A |
| 2022 | $27.10 Million | $43.70 Billion | $849.57 Million | 0.00x | 0.03x |
| 2023 | $21.56 Million | $57.92 Billion | -$1.18 Billion | 0.00x | N/A |
| 2024 | $15.57 Million | $55.68 Billion | -$5.22 Billion | 0.00x | N/A |
Competitor Companies of 018620 by Market Capitalization
Companies near WooGene B&G Co. Ltd in the global market cap rankings as of September 18, 2026. Review tangible net worth ratio of WooGene B&G Co. Ltd to assess the quality of the company's equity after excluding intangible assets.
Key companies related to WooGene B&G Co. Ltd by market ranking:
- Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #5605 globally with a market cap of $2.37 Billion USD ( ₩3.50 Trillion KRW).
- ST Pharm Co.Ltd (KQ:237690): Ranked #8267 globally with a market cap of $1.16 Billion USD ( ₩1.71 Trillion KRW).
- NatureCell Co.Ltd (KQ:007390): Ranked #9464 globally with a market cap of $884.84 Million USD ( ₩1.31 Trillion KRW).
- Oscotec Inc (KQ:039200): Ranked #10523 globally with a market cap of $713.20 Million USD ( ₩1.05 Trillion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #5605 | Sam Chun Dang Pharm. Co. Ltd | KQ:000250 | $2.37 Billion | ₩163500.00 |
| #8267 | ST Pharm Co.Ltd | KQ:237690 | $1.16 Billion | ₩91900.00 |
| #9464 | NatureCell Co.Ltd | KQ:007390 | $884.84 Million | ₩24600.00 |
| #10523 | Oscotec Inc | KQ:039200 | $713.20 Million | ₩37450.00 |
WooGene B&G Co. Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, WooGene B&G Co. Ltd's market cap moved from $62.83 Million to $ 47.07 Million, with a yearly change of -1.92%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩47.07 Million | +221.90% |
| 2025 | ₩14.62 Million | -6.10% |
| 2024 | ₩15.57 Million | -27.76% |
| 2023 | ₩21.56 Million | -20.45% |
| 2022 | ₩27.10 Million | -26.67% |
| 2021 | ₩36.95 Million | -26.96% |
| 2020 | ₩50.59 Million | +17.35% |
| 2019 | ₩43.11 Million | +31.76% |
| 2018 | ₩32.72 Million | -52.56% |
| 2017 | ₩68.97 Million | -27.71% |
| 2016 | ₩95.40 Million | +51.83% |
| 2015 | ₩62.83 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of WooGene B&G Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $47.07 Million USD |
| MoneyControl | $47.07 Million USD |
| MarketWatch | $47.07 Million USD |
| marketcap.company | $47.07 Million USD |
| Reuters | $47.07 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About WooGene B&G Co. Ltd
WooGene B&G Co., Ltd. develops, manufactures, and markets products to animal health and livestock industry in South Korea and internationally. The company's products include veterinary medicines, raw materials, and probiotic. It offers veterinary medicines for poultry, swine, bovine, horse, dog, cat, sheep, deer, and aquaculture markets; and vaccines for swine, poultry, canine, and cow markets. T… Read more